Live Cell Imaging Market

Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies, Research Institutes) - Global Forecasts to 2023

Report Code : BT 3390
Published ON : Feb, 2019

[158 Pages Report] The global live cell imaging market is expected to reach USD 2.9 billion by 2023 from an estimated USD 1.9 billion in 2018, at a CAGR of 8.9%. Growth in the live cell imaging market can primarily be attributed to various factors such as the growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and the growth in funding for research.

Live Cell Imaging Market

By type, the microscopes segment is estimated to hold the largest share of the live cell imaging instruments market

Based on type, the market is segmented into microscopes, standalone systems, cell analyzers, and accessories. In 2018, the microscopes segment accounted for the largest share of the live cell imaging instruments market. Increasing studies into cell behavior and the need to correlate multiple events and markers with cell morphology, favorable funding scenario for R&D in microscopy, rising focus on regenerative medicine, technological advancements in microscopes, and favorable regulatory procedures in order to launch new instruments in the market are the key factors driving the growth of the microscopes market.

By type, the reagents segment is estimated to hold the largest share of the live cell imaging consumables market

On the basis of type, the global live cell imaging consumables market is segmented into reagents, media, assay kits, and other consumables (microplates, slides, petri dishes, cover slips, and culture chambers). In 2018, the reagents segment accounted for the largest share of the consumables market. The large share of this segment can be attributed to the growing applications of biosciences and biotechnology within the pharmaceutical and healthcare fields. With advancements in technologies, the demand for high-quality reagents in biomedical research and processing is on the rise. The increasing demand for high-quality reagents and their repeated use in live cell imaging procedures are also factors driving the growth of this market.

The stem cells segment is expected to grow at the fastest rate during the forecast period

On the basis of application, the live cell imaging market is segmented into cell biology, stem cells, developmental biology, and drug discovery. The stem cells segment is expected to grow at the highest CAGR during the forecast owing to the increasing stem cell research activity and investments.

Live Cell Imaging Market

North America is expected to hold the largest market share during the forecast period

North America is the major revenue generating region in the live cell imaging market. The live cell imaging market in the region is driven by the availability of government funding for life science research, drug development regulations, advances in live cell imaging techniques, growth in the biotechnology and pharmaceutical industries, and the rising incidence of cancer.

Key Market Players

The key players in the live cell imaging market are Danaher Corporation (US), Carl Zeiss AG (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (US), GE Healthcare (US), Bruker Corporation (US), Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), BioTek Instruments (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), and NanoEnTek Inc. (Korea).

Recent Developments

  • Leica Microsystems (a subsidiary of Danaher Corporation) entered into an agreement with Triolab AS, a leading distributor of diagnostics and life science products.
  • In September 2018, Leica signed an agreement with Triolab to enable the latter supply and support Leica Microsystems’ confocal, and stereo microscope systems for the life science industry and sample preparation products for electron microscopy.
  • Carl Zeiss AG entered into a partnership with the Carl R. Woese Institute for Genomic Biology (IGB) (US).
  • In March 2017, Carl entered into a partnership with the Carl R. Woese Institute for Genomic Biology (IGB) to provide researchers around the US with access to the advanced technologies offered by Zeiss including the ZEISS Celldiscoverer 7, at IGB’s Core Facilities.
  • Bruker acquired Luxendo, a privately held spin-off of the European Molecular Biology Laboratory (EMBL) (Germany), a company that develops and manufactures light-sheet fluorescence microscopy instruments. In May 2017, Bruker acquired Luxendo to enable new research advances in live-cell imaging.

Key Questions addressed by the report

  • Which are the key players in the market and how intense is the competition?
  • Emerging countries have immense opportunities for the growth of live cell imaging market, will this scenario continue?
  • Which product market will dominate in future?
  • What are the challenges hindering the adoption of live cell imaging products?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 22)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Date From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1 Market Data Validation and Triangulation
    2.3 Assumptions for the Study

3 Executive Summary (Page No. - 31)

4 Premium Insights (Page No. - 36)
    4.1 Live Cell Imaging: Market Overview
    4.2 Live Cell Imaging Market, By Product and Service, 2018
    4.3 Live Cell Imaging Market, By Application, 2018
    4.4 Live Cell Imaging Market: Geographic Snapshot

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Adoption of High-Content Screening Techniques in Drug Discovery
                    5.2.1.2 Rising Incidence of Cancer
                    5.2.1.3 Growing Availability of Funds for Research
           5.2.2 Restraints
                    5.2.2.1 High Cost of High-Content Screening Systems
           5.2.3 Opportunities
                    5.2.3.1 Emerging Markets
                    5.2.3.2 Application of HCS in Personalized Medicine
           5.2.4 Challenges
                    5.2.4.1 Maintaining Cell Viability & Cellular Environment in the Culture
                    5.2.4.2 Dearth of Skilled Professionals

6 Live Cell Imaging Market, By Product & Service (Page No. - 45)
    6.1 Introduction
    6.2 Instruments
           6.2.1 Increasing Demand for Live Cells for Analysis in the Biotechnology and Biopharmaceutical Industries to Drive the Adoption of Live Cell Imaging Instruments
           6.2.2 Microscopes
           6.2.3 Standalone Systems
           6.2.4 Cell Analyzers
           6.2.5 Accessories
    6.3 Consumables
           6.3.1 Reagents
                    6.3.1.1 Reagents Segment to Account for the Largest Share of the Live Cell Imaging Consumables Market in 2018
           6.3.2 Assay Kits
                    6.3.2.1 Repeat Purchase of Assay Kits - Key Driver for Market Growth
           6.3.3 Media
                    6.3.3.1 Development of New and Advanced Technologies has Resulted in an Increased Demand for High-Quality Media in Biomedical Research and Processing
           6.3.4 Other Consumables
    6.4 Software
           6.4.1 Technological Advancements in Image Acquisition - A Key Driver for Market Growth
    6.5 Services
           6.5.1 Availability of A Wide Range of Services and Growing Number of Initiatives By Key Players to Drive the Services Market

7 Live Cell Imaging Market, By Application (Page No. - 60)
    7.1 Introduction
    7.2 Cell Biology
           7.2.1 Increasing Prevalence of Cancer to Drive the Cell Biology Application Segment
    7.3 Stem Cells
           7.3.1 Importance of Stem Cell Research has Boosted Investments in This Area
    7.4 Developmental Biology
           7.4.1 Growing Research in Developmental Biology A Key Driver of Market Growth
    7.5 Drug Discovery
           7.5.1 Use of HCS Cell-Based Assays has Grown in Drug Development Studies

8 Live Cell Imaging Market, By End User (Page No. - 67)
    8.1 Introduction
    8.2 Pharmaceutical & Biotechnology Companies
           8.2.1 Increasing R&D Activities and the Patent Cliff of Various Blockbuster Drugs to Increase the Demand for Live Cell Imaging Products in Pharmaceutical and Biotechnology Companies
    8.3 Academic & Research Institutes
           8.3.1 Demand for Live Cell Imaging Products to Increase in Academic and Research Institutes Owing to the Rising Focus of These End Users on Strengthening Their Own Drug Discovery Research Programs
    8.4 Contract Research Organizations
           8.4.1 Growing Outsourcing of R&D Activities By Pharmaceutical Companies to Drive the Demand for Live Cell Imaging Systems in Contract Research Organizations

9 Live Cell Imaging Market, By Region (Page No. - 72)
    9.1 Introduction
    9.2 North America
           9.2.1 US
                    9.2.1.1 US Dominates the North American Live Cell Imaging Market Primarily Due to the Strong Trend of Pharmaceutical & Biotechnology Research and the High Burden of Cancer
           9.2.2 Canada
                    9.2.2.1 Government Initiatives to Promote Research and the Need to Combat Cancer are the Key Factors Driving the Growth of the Live Cell Imaging Market in Canada
    9.3 Europe
           9.3.1 Germany
                    9.3.1.1 Presence of A Large Number of Academic Research Institutes and Increasing R&D Spending to Drive the Demand for Live Cell Imaging in Germany
           9.3.2 UK
                    9.3.2.1 UK has Seen A Surge in the Prevalence of Cancer; By 2030, an Estimated 4 Million People are Expected to Be Diagnosed With the Disease
           9.3.3 France
                    9.3.3.1 Growth in the French Live Cell Imaging Market is Attributed to the Large Pharmaceutical Manufacturing Industry and the High Public Expenditure on R&D in France
           9.3.4 Rest of Europe (RoE)
    9.4 Asia Pacific
           9.4.1 China
                    9.4.1.1 China to Register the Highest Growth Rate in the Asia Pacific Live Cell Imaging Market During the Forecast Period
           9.4.2 Japan
                    9.4.2.1 Increasing Aging Population, Rising Prominence for Regenerative Medicine Research, and Increasing Number of Researchers to Support Market Growth in Japan
           9.4.3 India
                    9.4.3.1 Favorable Changes in Foreign Direct Investment (FDI) Regulations in the Pharmaceutical Industry to Drive Market Growth
           9.4.4 RoAPAC
    9.5 RoW

10 Competitive Landscape (Page No. - 113)
     10.1 Introduction
     10.2 Live Cell Imaging Market Share Analysis (2017)
     10.3 Competitive Leadership Mapping
             10.3.1 Visionary Leaders
             10.3.2 Innovators
             10.3.3 Dynamic Differentiators
             10.3.4 Emerging Companies
     10.4 Competitive Scenario

11 Company Profiles (Page No. - 120)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     11.1 Danaher Corporation
     11.2 Carl Zeiss AG
     11.3 Nikon Corporation
     11.4 Olympus Corporation
     11.5 Perkinelmer
     11.6 GE Healthcare
     11.7 Bruker
     11.8 Thermo Fisher Scientific
     11.9 Sartorius AG
     11.10 Biotek Instruments
     11.11 Etaluma
     11.12 Cytosmart Technologies
     11.13 Nanoentek

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 151)
     12.1 Discussion Guide: Live Cell Imaging Market
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Available Customizations
     12.4 Related Reports
     12.5 Author Details


List of Tables (88 Tables)

Table 1 Market, By Product & Service, 2016–2023 (USD Million)
Table 2 Live Cell Imaging Instruments Market, By Type, 2016–2023 (USD Million)
Table 3 Live Cell Imaging Instruments Market, By Country, 2016–2023 (USD Million)
Table 4 Live Cell Imaging Microscopes Market, By Country, 2016–2023 (USD Million)
Table 5 Live Cell Imaging Standalone Systems Market, By Country, 2016–2023 (USD Million)
Table 6 Live Cell Imaging Cell Analyzers Market, By Country, 2016–2023 (USD Million)
Table 7 Live Cell Imaging Accessories Market, By Country, 2016–2023 (USD Million)
Table 8 Live Cell Imaging Consumables Market, By Type, 2016–2023 (USD Million)
Table 9 Live Cell Imaging Consumables Market, By Country, 2016–2023 (USD Million)
Table 10 Live Cell Imaging Reagents Market, By Country, 2016–2023 (USD Million)
Table 11 Live Cell Imaging Assay Kits Market, By Country, 2016–2023 (USD Million)
Table 12 Live Cell Imaging Media Market, By Country, 2016–2023 (USD Million)
Table 13 Live Cell Imaging Other Consumables Market, By Country, 2016–2023 (USD Million)
Table 14 Live Cell Imaging Software Market, By Country, 2016–2023 (USD Million)
Table 15 Live Cell Imaging Services Market, By Country, 2016–2023 (USD Million)
Table 16 Market, By Application, 2016–2023 (USD Million)
Table 17 Market for Cell Biology, By Country, 2016–2023 (USD Million)
Table 18 Market for Stem Cells, By Country, 2016–2023 (USD Million)
Table 19 Market for Developmental Biology, By Country, 2016–2023 (USD Million)
Table 20 Market for Drug Discovery, By Country, 2016–2023 (USD Million)
Table 21 Market, By End User, 2016–2023 (USD Million)
Table 22 Market for Pharmaceutical & Biotechnology Companies, By Country, 2016–2023 (USD Million)
Table 23 Market for Academic & Research Institutes, By Country, 2016–2023 (USD Million)
Table 24 Market for Contract Research Organizations, By Country, 2016–2023 (USD Million)
Table 25 Market, By Region, 2016–2023 (USD Million)
Table 26 North America: Live Cell Imaging Market, By Country, 2016–2023 (USD Million)
Table 27 North America:  Market, By Product & Service, 2016–2023 (USD Million)
Table 28 North America: Live Cell Imaging Consumables Market, By Type, 2016–2023 (USD Million)
Table 29 North America: Market, By Application, 2016–2023 (USD Million)
Table 30 North America: Market, By End User, 2016–2023 (USD Million)
Table 31 US: Live Cell Imaging Market, By Product & Service, 2016–2023 (USD Million)
Table 32 US: Live Cell Imaging Consumables Market, By Type, 2016–2023 (USD Million)
Table 33 US: Market, By Application, 2016–2023 (USD Million)
Table 34 US: Market, By End User, 2016–2023 (USD Million)
Table 35 Canada: Market, By Product & Service, 2016–2023 (USD Million)
Table 36 Canada: Live Cell Imaging Consumables Market, By Type, 2016–2023 (USD Million)
Table 37 Canada: Market, By Application, 2016–2023 (USD Million)
Table 38 Canada: Market, By End User, 2016–2023 (USD Million)
Table 39 Europe: Live Cell Imaging Market, By Country, 2016–2023 (USD Million)
Table 40 Europe: Market, By Product & Service, 2016–2023 (USD Million)
Table 41 Europe: Live Cell Imaging Consumables Market, By Type, 2016–2023 (USD Million)
Table 42 Europe: Market, By Application, 2016–2023 (USD Million)
Table 43 Europe: Market, By End User, 2016–2023 (USD Million)
Table 44 Germany: Market, By Product & Service, 2016–2023 (USD Million)
Table 45 Germany: Live Cell Imaging Consumables Market, By Type, 2016–2023 (USD Million)
Table 46 Germany: Market, By Application, 2016–2023 (USD Million)
Table 47 Germany: Market, By End User, 2016–2023 (USD Million)
Table 48 UK: Market, By Product & Service, 2016–2023 (USD Million)
Table 49 UK: Live Cell Imaging Consumables Market, By Type, 2016–2023 (USD Million)
Table 50 UK: Market, By Application, 2016–2023 (USD Million)
Table 51 UK: Market, By End User, 2016–2023 (USD Million)
Table 52 France: Market, By Product & Service, 2016–2023 (USD Million)
Table 53 France: Live Cell Imaging Consumables Market, By Type, 2016–2023 (USD Million)
Table 54 France: Market, By Application, 2016–2023 (USD Million)
Table 55 France: Market, By End User, 2016–2023 (USD Million)
Table 56 RoE: Market, By Product & Service, 2016–2023 (USD Million)
Table 57 RoE: Live Cell Imaging Consumables Market, By Type, 2016–2023 (USD Million)
Table 58 RoE: Market, By Application, 2016–2023 (USD Million)
Table 59 RoE: Live Cell Imaging Market, By End User, 2016–2023 (USD Million)
Table 60 Asia Pacific: Market, By Country, 2016–2023 (USD Million)
Table 61 Asia Pacific: Live Cell Imaging Market, By Product & Service, 2016–2023 (USD Million)
Table 62 Asia Pacific: Live Cell Imaging Consumables Market, By Type, 2016–2023 (USD Million)
Table 63 Asia Pacific: Market, By Application, 2016–2023 (USD Million)
Table 64 Asia Pacific: Market, By End User, 2016–2023 (USD Million)
Table 65 China: Live Cell Imaging Market, By Product & Service, 2016–2023 (USD Million)
Table 66 China: Live Cell Imaging Consumables Market, By Type, 2016–2023 (USD Million)
Table 67 China: Market, By Application, 2016–2023 (USD Million)
Table 68 China: Market, By End User, 2016–2023 (USD Million)
Table 69 Japan: Market, By Product & Service, 2016–2023 (USD Million)
Table 70 Japan: Live Cell Imaging Consumables Market, By Type, 2016–2023 (USD Million)
Table 71 Japan: Market, By Application, 2016–2023 (USD Million)
Table 72 Japan: Market, By End User, 2016–2023 (USD Million)
Table 73 India: Live Cell Imaging Market, By Product & Service, 2016–2023 (USD Million)
Table 74 India: Live Cell Imaging Consumables Market, By Type, 2016–2023 (USD Million)
Table 75 India: Market, By Application, 2016–2023 (USD Million)
Table 76 India: Market, By End User, 2016–2023 (USD Million)
Table 77 RoAPAC: Market, By Product & Service, 2016–2023 (USD Million)
Table 78 RoAPAC: Live Cell Imaging Consumables Market, By Type, 2016–2023 (USD Million)
Table 79 RoAPAC: Market, By Application, 2016–2023 (USD Million)
Table 80 RoAPAC: Market, By End User, 2016–2023 (USD Million)
Table 81 RoW: Market, By Product & Service, 2016–2023 (USD Million)
Table 82 RoW: Live Cell Imaging Consumables Market, By Type, 2016–2023 (USD Million)
Table 83 RoW: Market, By Application, 2016–2023 (USD Million)
Table 84 RoW: Market, By End User, 2016–2023 (USD Million)
Table 85 Product Launches and Enhancements, 2015-2018
Table 86 Agreements, Contracts, Collaborations, and Partnerships, 2015-2018
Table 87 Acquisitions, 2015-2018
Table 88 Expansions, 2015-2018


List of Figures (38 Figures)

Figure 1 Live Cell Imaging Market Segmentation
Figure 2 Live Cell Imaging Market: Research Methodology
Figure 3 Research Design
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Market Share, By Product and Service (2018)
Figure 9 Microscopes Segment Held the Largest Share of the Live Cell Imaging Instruments Market in 2018
Figure 10 Live Cell Imaging Consumables Market Share, By Type (2018)
Figure 11 Cell Biology Applications to Dominate the Live Cell Imaging Market During the Forecast Period
Figure 12 Pharmaceutical & Biotechnology Companies Segment Held the Largest Share of the Live Cell Imaging Market in 2018
Figure 13 Asia Pacific to Register the Highest CAGR in the Forecast Period
Figure 14 Growing Adoption of HCS Techniques and Rising Incidence of Cancer are Key Factors Driving Market Growth
Figure 15 Instruments Dominated the North American Market in 2018
Figure 16 Cell Biology Accounted for the Largest Share of the European Market in 2018
Figure 17 China is Expected to Grow at the Highest CAGR During the Forecast Period
Figure 18 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Instruments Segment to Dominate the Market During the Forecast Period
Figure 20 Cell Biology Applications to Dominate the Market During the Forecast Period
Figure 21 Market, By End User, 2018 vs 2023 (USD Million)
Figure 22 Market, By Region, 2018 vs 2023 (USD Million)
Figure 23 North America: Market Snapshot
Figure 24 Europe: Market Snapshot
Figure 25 Asia Pacific: Market Snapshot
Figure 26 RoW: Market Snapshot
Figure 27 Key Developments in the Market Between 2015 and 2018
Figure 28 Market Share Analysis, By Key Player, 2017
Figure 29 Market (Global) Competitive Leadership Mapping (2017)
Figure 30 Danaher Corporation: Company Snapshot (2017)
Figure 31 Carl Zeiss AG: Company Snapshot (2017)
Figure 32 Nikon Corporation: Company Snapshot (2017)
Figure 33 Olympus Corporation: Company Snapshot (2017)
Figure 34 Perkinelmer: Company Snapshot (2017)
Figure 35 GE Healthcare: Company Snapshot (2017)
Figure 36 Bruker: Company Snapshot (2017)
Figure 37 Thermo Fisher Scientific: Company Snapshot (2017)
Figure 38 Sartorius: Company Snapshot (2017)

The study involved four major activities to estimate the current market size of the live cell imaging market. Exhaustive secondary research was done to collect information about the market, peer markets, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chain through primary research. Thirdly, both top-down and bottom-up approaches were employed to estimate the complete market size. Finally, the market breakdown and data triangulation was used to estimate the market size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as the Microscopy Society of America, European Microscopy Society, Australian Microscopy and Microanalysis Society, Canadian Cytometry and Microscopy Association, International Pharmaceutical Federation, American Society for Cell Biology, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Association of the British Pharmaceutical Industry (ABPI), Indian Drug Manufacturers Association, Canadian Society for Pharmaceutical Sciences (CSPS), National Institute for Pharmaceutical Research and Development (NIPRD), Physiological Society, The Centre for Cell Imaging (CCI), Society of Biomolecular Imaging and Informatics, Irish National Centre for High Content Screening (INCHSA), National Institute of General Medical Sciences (NIGMS), directories, industry journals, databases, press releases, and annual reports of the companies have been used to identify and collect information useful for the study of this market.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the live cell imaging market.

  • A robust primary research methodology has been adopted to validate the contents of the report
  • Both telephonic and e-mail interviews of primary participants were conducted through questionnaires

Following the breakdown of primary respondents

Live Cell Imaging Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Top-down and bottom-up approaches were used to validate the size of the live cell imaging market and estimate the size of other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both, the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the live cell imaging market by product & service, application, end user, and region
  • To provide detailed information regarding factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To strategically analyze the market structure and profile the key players of the live cell imaging market and comprehensively analyze their core competencies
  • To forecast the size of the market segments in North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
  • To track and analyze competitive developments such as product launches, product enhancements, expansions, acquisitions, partnerships, contracts, collaborations, and agreements

Scope of the Report

Report Metric

Details

Market size available for years

2016-2023

Base year considered

2017

Forecast period

2018–2023

Forecast units

Value (USD)

Segments covered

Product & Service, Application, End User, and Region

Geographies covered

North America, Europe, Asia Pacific, and RoW

Companies covered

Danaher Corporation (US), Carl Zeiss AG (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (US), GE Healthcare (US), Bruker Corporation (US), Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), BioTek Instruments (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), and NanoEnTek Inc. (Korea)

This research report categorizes the live cell imaging market based on product & service, application, end user, and region.

On the basis of Product, the live cell imaging market has been segmented as follows:

  • Product & Service
    • Instruments
      • Microscopes
      • Standalone Systems
      • Cell Analyzers
      • Accessories
    • Consumables
      • Reagents
      • Assay Kits
      • Media
      • Other Consumables
    • Software
    • Services

On the basis of End User, the live cell imaging market has been segmented as follows:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

On the basis of Application, the live cell imaging market has been segmented as follows

  • Cell Biology
  • Stem Cells
  • Developmental Biology
  • Drug Discovery

On the basis of Region, the live cell imaging market has been segmented as follows:

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe (RoE)
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific (ROAPAC)
  • Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Company Information

  • Detailed analysis and profiling of additional market players (up to 3)
  • SHARE
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Live Cell Imaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home